GV
Ganesh Venkatraman
VIT University School of Bio Science and Technology, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Fels Institute for Cancer Research & Molecular Biology
0000-0003-0179-9785
Employment
-
VIT University School of Bio Science and Technology Professor2023 - Present
-
Sri Ramachandra Institute of Higher Education and Research (Deemed to be University) Professor2008 - 2023
Education
-
Fels Institute for Cancer Research & Molecular Biology PDF2007 - 2008
-
University of Nebraska Medical Center College of Medicine PDF2004 - 2007
-
Cancer Institute Ph.D2001 - 2005
Projects & Funding
Projects & funding information is unavailable.
Publications (111)
- PELP1 expression is associated with disease progression in inflammation-driven oral cancer Save
- PAK1 mediated phosphorylation of ARGLU1 promotes tumorigenic potential of Breast cancer Save
- Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers Save
- Supplementary Figure S1 from Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer Save
- Supplementary Figure S10 from Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer Save
- Supplementary Figure S11 from Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer Save
- Supplementary Figure S12 from Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer Save
- Supplementary Figure S13 from Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer Save
- Supplementary Figure S14 from Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer Save
- Supplementary Figure S15 from Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer Save